Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,413,825 papers from all fields of science
Search
Sign In
Create Free Account
indanocine
Known as:
indanosine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Indans
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Binding of indanocine to the colchicine site on tubulin promotes fluorescence, and its binding parameters resemble those of the colchicine analogue AC.
Lalita Das
,
Suvroma Gupta
,
D. Dasgupta
,
Asim Poddar
,
Mark E. Janik
,
B. Bhattacharyya
Biochemistry
2009
Corpus ID: 22556137
Indanocine, a synthetic indanone, has shown potential antiproliferative activity against several tumor types. It is different…
Expand
2001
2001
Biochemical genetic analysis of indanocine resistance in human leukemia.
Xuequn Helen Hua
,
D. Genini
,
+5 authors
Lorenzo M. Leoni
Cancer Research
2001
Corpus ID: 17503632
Indanocine is a potent tubulin-binding drug that is cytotoxic to multidrug-resistant cancer cell lines. We demonstrated that…
Expand
2001
2001
Mechanism of Action of Substituted Indanones in Multidrug Resistant Breast Cancer
L. Leoni
2001
Corpus ID: 70620285
Abstract : Mechanism of Action of Substituted Indanones in Multidrug Resistant Breast Cancer Our laboratory has recently…
Expand
2000
2000
Tubulin as a target for anticancer drugs.
E. von Angerer
Current opinion in drug discovery & development
2000
Corpus ID: 23591981
Nature provides a large spectrum of agents that either inhibit the polymerization of tubulin or prevent the disassembly of…
Expand
2000
2000
Understanding apoptosis involved in the development and treatment of malignancies
D. Genini
2000
Corpus ID: 82557174
Apoptosis is a key event occurring in living organisms. In order to maintain tissue homeostasis, a comparable number of cells…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE